Nosocomial infeccion with Candida Haemulonii in an older infant or toddler
DOI:
https://doi.org/10.18041/2390-0512/biociencias.1.6369Keywords:
Candida haemulonii, Caspofungin, Nosocomial, Infant, Cardiac affectionAbstract
Introduction: Candida species are the main causal microorganisms of opportunistic mycoses in the hospital environment. C. haemulonii is a species of Candida non albicans, which is increasingly reported in healthcare centers around the world, thus gaining the interest of public health entities. Clinical case: A nosocomial infection by C. haemulonii is reported in a pediatric patient with a heart condition in the Barranquilla district, Colombia. Discussion and conclusion: Reports of C. haemulonii are scarce in Colombia. While the use of catheters and devices used in patients could be spreading to C haemulonii to patients residing in PICUs. It is concluded that the treatment with the antifungal (caspofungin) used in the minor, was successful.
Downloads
Download data is not yet available.
References
Bolyard E a, Tablan OC, Williams WW, Pearson ML, Craig NS, Deitchman SD, et al. Guideline for infection control in health care personnel. Am J Infect Control. 1998;26:289–354.
2. Organización Mundial de la Salud. Prevención de las infecciones nosocomiales. Guía prática. Vol. 2. 2002. p. 70.
3. Izquierdo G, Santolaya ME. Candidiasis invasoras en recién nacidos: diagnóstico, tratamiento y prevención. Rev Chil Infectol. 2014;31(1):73–83.
4. Tsuji OV, Rivera TC. Articulo de revisión: Candidemia. Acta pediatr Mex. 2006;27(1):30–5.
5. Laura Rosio Castañón Olivares. Candidiasis. UNAM. 2016. p. 9.
6. Cornistein W, Mora A, Orellana N, Capparelli FJ, del Castillo M. Candida: epidemiología y factores de riesgo para especies no albicans. Enferm Infecc Microbiol Clin [Internet]. 2013;31(6):380–4. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0213005X12003229
7. Ramos LS, Figueiredo-Carvalho MHG, Barbedo LS, Ziccardi M, Chaves ALS, Zancopé-Oliveira RM, et al. Candida haemulonii complex: Species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2015;70(1):111–5.
8. Nobrega de Almeida J, Pontes Lima JA, Levin AS, Negro GMB Del, Giudice MC, Tringoni MP, et al. Candida haemulonii Complex Species, Brazil, January 2010 - March 2015. Emerg Infect Dis. 2016;22(3):561–3.
9. Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, et al. Multidrug-resistant candida haemulonii and C. Auris, tel aviv, Israel. Emerg Infect Dis. 2017;23(2):195–203.
10. Kumar A, Prakash A, Singh A, Kumar H, Hagen F, Meis JF, et al. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and ampli fi ed fragment-length polymorphism analyses. Emerg Microbes Infect [Internet]. 2016;5:e49-3. Available from: http://dx.doi.org/10.1038/emi.2016.49
11. Meza YP, Quintero CP, Varela YP. Aspectos epidemiológicos de la sepsis, en unidades de cuidados intensivos Santa Marta, Colombia. Rev Duazary. 2016;13(2):126–32.
12. Wang H, Liu N, Yin M, Han H, Yue J, Zhang F, et al. The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: A multicentre retrospective study. BMC Infect Dis. 2014;14(1):1–9.
13. Bravo J, Larrarte C, Quiñonez S, Echeverri J, Quiroga C, Gómez C. Candida haemulonii : causa infrecuente de peritonitis asociada a diálisis peritoneal. Infectio. 2018;22(1):58–60.
14. Lehmann PF, Wu LC, Pruitt WR, Meyer SA, Ahearn DG. Unrelatedness of groups of yeasts within the Candida haemulonii complex. J Clin Microbiol. 1993;31(7):1683–7.
15. Rodero L, Cuenca-Estrella M, Córdoba S, Cahn P, Davel G, Kaufman S, et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol. 2002;40(6):2266–9.
16. Kim M, Shin JH, Sung H, Lee K, Kim E, Ryoo N, et al. Candida haemulonii and Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features. Clin Infect Dis. 2009;48:e57-61.
17. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55(8):2445–52.
18. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by vitek 2, CL. J Clin Microbiol. 2015;53(6):1823–30.
19. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients Peter. Clin Infect Dis. 2003;37:634–43.
20. Duarte JM, Betts R, Rotstein C, Colombo AL, –Moya LT, Smietana J, et al. Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis. N Engl J Med [Internet]. 2002;347(25):2020–9. Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa021585
2. Organización Mundial de la Salud. Prevención de las infecciones nosocomiales. Guía prática. Vol. 2. 2002. p. 70.
3. Izquierdo G, Santolaya ME. Candidiasis invasoras en recién nacidos: diagnóstico, tratamiento y prevención. Rev Chil Infectol. 2014;31(1):73–83.
4. Tsuji OV, Rivera TC. Articulo de revisión: Candidemia. Acta pediatr Mex. 2006;27(1):30–5.
5. Laura Rosio Castañón Olivares. Candidiasis. UNAM. 2016. p. 9.
6. Cornistein W, Mora A, Orellana N, Capparelli FJ, del Castillo M. Candida: epidemiología y factores de riesgo para especies no albicans. Enferm Infecc Microbiol Clin [Internet]. 2013;31(6):380–4. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0213005X12003229
7. Ramos LS, Figueiredo-Carvalho MHG, Barbedo LS, Ziccardi M, Chaves ALS, Zancopé-Oliveira RM, et al. Candida haemulonii complex: Species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2015;70(1):111–5.
8. Nobrega de Almeida J, Pontes Lima JA, Levin AS, Negro GMB Del, Giudice MC, Tringoni MP, et al. Candida haemulonii Complex Species, Brazil, January 2010 - March 2015. Emerg Infect Dis. 2016;22(3):561–3.
9. Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, et al. Multidrug-resistant candida haemulonii and C. Auris, tel aviv, Israel. Emerg Infect Dis. 2017;23(2):195–203.
10. Kumar A, Prakash A, Singh A, Kumar H, Hagen F, Meis JF, et al. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and ampli fi ed fragment-length polymorphism analyses. Emerg Microbes Infect [Internet]. 2016;5:e49-3. Available from: http://dx.doi.org/10.1038/emi.2016.49
11. Meza YP, Quintero CP, Varela YP. Aspectos epidemiológicos de la sepsis, en unidades de cuidados intensivos Santa Marta, Colombia. Rev Duazary. 2016;13(2):126–32.
12. Wang H, Liu N, Yin M, Han H, Yue J, Zhang F, et al. The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: A multicentre retrospective study. BMC Infect Dis. 2014;14(1):1–9.
13. Bravo J, Larrarte C, Quiñonez S, Echeverri J, Quiroga C, Gómez C. Candida haemulonii : causa infrecuente de peritonitis asociada a diálisis peritoneal. Infectio. 2018;22(1):58–60.
14. Lehmann PF, Wu LC, Pruitt WR, Meyer SA, Ahearn DG. Unrelatedness of groups of yeasts within the Candida haemulonii complex. J Clin Microbiol. 1993;31(7):1683–7.
15. Rodero L, Cuenca-Estrella M, Córdoba S, Cahn P, Davel G, Kaufman S, et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol. 2002;40(6):2266–9.
16. Kim M, Shin JH, Sung H, Lee K, Kim E, Ryoo N, et al. Candida haemulonii and Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features. Clin Infect Dis. 2009;48:e57-61.
17. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55(8):2445–52.
18. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by vitek 2, CL. J Clin Microbiol. 2015;53(6):1823–30.
19. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients Peter. Clin Infect Dis. 2003;37:634–43.
20. Duarte JM, Betts R, Rotstein C, Colombo AL, –Moya LT, Smietana J, et al. Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis. N Engl J Med [Internet]. 2002;347(25):2020–9. Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa021585
Downloads
Published
2020-05-26
Issue
Section
CASE REPORTS
